Inovio Pharmaceuticals Investor

Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Technology: COVID
Industry: DNA
Headquarters: Plymouth Meeting, Pennsylvania, United States
Founded Date: 1979-01-01
Employees Number: 251-500
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A
Investors Number: 6
Total Funding: 446383430
Estimated Revenue: $50M to $100M
Last Funding Date: 2021-01-20
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership